|
GCH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.980200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.041230E-01 |
| Normal-vs-Stage2 |
1.035160E-03 |
| Normal-vs-Stage3 |
1.751690E-02 |
| Normal-vs-Stage4 |
1.360230E-02 |
| Stage1-vs-Stage2 |
2.176800E-04 |
| Stage1-vs-Stage3 |
6.152400E-02 |
| Stage1-vs-Stage4 |
8.034200E-02 |
| Stage2-vs-Stage3 |
7.663600E-02 |
| Stage2-vs-Stage4 |
2.803400E-01 |
| Stage3-vs-Stage4 |
6.341600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.073900E-02 |
| Normal-vs-AfricanAmerican |
1.536030E-02 |
| Normal-vs-Asian |
1.866610E-01 |
| Caucasian-vs-AfricanAmerican |
1.884790E-01 |
| Caucasian-vs-Asian |
4.404200E-01 |
| AfricanAmerican-vs-Asian |
7.950300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.482490E-02 |
| Normal-vs-Female |
4.301600E-02 |
| Male-vs-Female |
2.200200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.069400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.022400E-03 |
| Normal-vs-Age(61-80Yrs) |
9.981000E-03 |
| Normal-vs-Age(81-100Yrs) |
7.703600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.620400E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.220600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.882830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.549600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.972300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.638130E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.501600E-01 |
| Classical-VS-Follicular |
2.484500E-03 |
| Classical-VS-Other |
6.473800E-01 |
| Classical-VS-Normal |
5.412100E-02 |
| Tall-VS-Follicular |
5.686300E-02 |
| Tall-VS-Other |
5.977600E-01 |
| Tall-VS-Normal |
1.058780E-01 |
| Follicular-VS-Other |
6.228600E-01 |
| Follicular-VS-Normal |
2.124500E-03 |
| Other-VS-Normal |
8.786400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.361900E-02 |
| Normal-vs-N1 |
1.880370E-02 |
| N0-vs-N1 |
5.168000E-01 |
|
|
